With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

RubrYc has developed a unique molecular engineering approach to the discovery of epitope-selective antibodies. By combining greatly parallel in silico simulations, proprietary machine learning ...

2 Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of bispecific antibodies while reducing costs and enhancing downstream ...

Traditional antibody discovery procedures are often limited by the number of unique full-length antibodies that can be expressed and tested functionally or may deliver lead molecules that require ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

i-Ome™ Discovery is Sengenics’ most advanced protein microarray, meticulously designed for antibody and autoantibody profiling in biomarker discovery. This powerful platform delivers key insights into ...

Lilly has invested in ‘Islands of Automation’ to advance the B cell antibody discovery platform at the Lilly Biotechnology Center in San Diego with the goal of significantly increasing throughput and ...

In another example of the pharma industry embracing generative artificial intelligence (GenAI), Boehringer Ingelheim will use technology developed by IBM to rev up antibody discovery and development.

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set ...

Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.